Europe

Oct 24, 2018
Seven years ago, the UK Bribery Act 2010 was deemed revolutionary. Looking back, what has been its impact on pharma? Chris Cartmell and Jo Pisano report.
Oct 09, 2018
Pharmaceutical Executive
What will come out of Austria’s shakeup of European pharma rules? Reflector reports.
Aug 24, 2018
A recently announced collaboration between EUnetHTA, WHO, and ISPOR brings home the fact that there is still no real agreement on a definition of HTA, writes Reflector.
Aug 01, 2018
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.
Jul 27, 2018
Artificial intelligence adoption by pharma companies in the UK demands a new, agile governance layer, write Tim Wright and Antony Bott.
Jul 09, 2018
Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 19, 2018
Figuring out the workings of the EU in topics related to health can be akin to deciphering Egyptian hieroglyphs, making it challenging for companies to plan ahead, writes Reflector.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
May 16, 2018
Pharmaceutical Executive
Pair of EU meetings, while well-meant, offered little action and beg the question—what’s the true merit in working together?
native1_300x100
lorem ipsum